Skip to main content
. 2023 Oct 1;14(5):1483–1487. doi: 10.14336/AD.2023.0227

Table 1.

NBHO combined with Reperfusion Strategy. Experiments (NBHO + intravenous thrombolysis) were filled in purple, while experiments (NBHO+EVT) were filled in blank.

Study Sponsor Year Study Type Sample size Type of patients NBHO treatment and duration Outcome Efficacy
Shi et al. 2017 Cohort
Stufy
18 Patients with acute ischemic stroke Oxygen, 10L/min, 4 hours, by facemask Blood Occludin and Claudin-5 Levels (baseline-24hours-72 h)
NIHSS (1.3.7days)
Beneificial
Li na 2021 Observational study 227
(125+102)
125 patients received NBHO therapy combined with intravenous thrombolysis, while 102 patients received intravenous thrombolysis only. Oxygen, 10L/min, 4 hours, by facemask mRS at 90 days Beneificial
Cheng et al. 2021 Prospective
RCT
180
(91+89)
stroke patients with large vessel occlusion high-flow NBHO by a Venturi mask (FiO2 50%, flow 15 L/min)
Starting After vessel recanalization for 6 h
mRS at 90 days Beneificial
Poli et al. 2017 Single-blind
RCT
456 Patients with acute ischemic stroke due to large vessel occlusion likely to receive endovascular mechanical thrombectomy 100% oxygen, ≥ 40 L/min, via a sealed non-rebreather facemask with reservoir Ischemic core growth from baseline to 24 hours On going
Li et al. 2018 Single-blind
RCT
86 Patients with acute ischemic stroke who received endovascular treatment Oxygen, 10L/min, via oxygen storage facemask Cerebral infarct volume evaluated through MRI (DWI), 24-48 h after randomization Beneificial
Li et al. 2021 triple-blind
RCT
280 patients with indications for endovascular thrombectomy, who randomized<6 hours after stroke onset 100% oxygen (≤30min after admission), 10L/min, 4 hours, by a sealed non-ventilating oxygen storage mask mRS at 90 days On going

Abbreviations: NBHO, Normobaric Hyperoxia; NIHSS, the National Institute of Health Scale Score; RCT, Randomized Clinical Trial; mRS, modified Rankin Score; MRI, Magnetic Resonance Imaging; DWI, Diffusion Weighted Imaging.